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a b s t r a c t
Herpesviruses suppress cell death to assure sustained infection in their natural hosts. Murine
cytomegalovirus (MCMV) encodes suppressors of apoptosis as well as M45-encoded viral inhibitor of
RIP activation (vIRA) to block RIP homotypic interaction motif (RHIM)-signaling and recruitment of RIP3
(also called RIPK3), to prevent necroptosis. MCMV and human cytomegalovirus encode a viral inhibitor
of caspase (Casp)8 activation to block apoptosis, an activity that unleashes necroptosis. Herpes simplex
virus (HSV)1 and HSV2 incorporate both RHIM and Casp8 suppression strategies within UL39-encoded
ICP6 and ICP10, respectively, which are herpesvirus-conserved homologs of MCMV M45. Both HSV
proteins sensitize human cells to necroptosis by blocking Casp8 activity while preventing RHIM-
dependent RIP3 activation and death. In mouse cells, HSV1 ICP6 interacts with RIP3 and, surprisingly,
drives necroptosis. Thus, herpesviruses have illuminated the contribution of necoptosis to host defense
in the natural host as well as its potential to restrict cross-species infections in nonnatural hosts.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
Necroptosis is a form of programmed cell death leading to
membrane leakage independent of caspases, orchestrated by the
activity of receptor interacting protein (RIP)3 kinase and its target, a
pseudokinase called mixed lineage kinase-like (MLKL). Hallmark
insights using vaccinia virus raised the specter of RIP3 kinase-
dependent necroptosis contributing to antiviral host defense (Cho
et al., 2009). The identiﬁcation of a speciﬁc viral inhibitor of RIP
activation (vIRA) encoded by the herpesvirus murine cytomegalo-
virus (MCMV) demonstrated that RIP3-mediated necroptosis is a
bona ﬁde cell autonomous host defense pathway subjected to a
speciﬁc viral countermeasure (Upton et al., 2010, 2012). Necroptosis
has been implicated in additional viral (Berger and Danthi, 2013; Guo
et al., 2015) as well as bacterial (Robinson et al., 2012; Weng et al.,
2014) infections and is probably a default pathway when caspase
(Casp)8 activity is compromised in cells with sufﬁcient levels of RIP3
(Upton and Chan, 2014; Kaiser et al., 2013). Many viruses, including
both poxviruses and herpesviruses, inhibit caspase (Casp)8 activity
(Mocarski et al., 2011) and therefore have the potential to unleash
this alternate death pathway. For example, the betaherpesvirus-
conserved viral inhibitor of Casp8 activation (vICA) naturally sup-
presses virus-induced apoptosis in macrophages (Menard et al.,
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2003; McCormick et al., 2003, 2010; Skaletskaya et al., 2001; Cicin-
Sain et al., 2008). MCMV relies on M45-encoded vIRA to prevent
necroptosis and sustain infection. The M45 protein is an enzymati-
cally inactive homolog of the large subunit (R1) of ribonucleotide
reductase (RNR) common across the herpesviruses. Based on studies
of MCMV, we have posited that an evolutionary dialog has gone on
between host cell death pathways and virus-encoded cell death
suppressors that is evident in mammals (Kaiser et al., 2013; Mocarski
et al., 2014), as depicted in Fig. 1. Mitochondrial, or cell-intrinsic cell
death is an ancient form of host defense as well as a common target
of virus-encoded suppressors that provide the selective pressure for
Casp8 extrinsic apoptosis to side-step mitochondria and directly
activate the executioner caspases, Casp3 and Casp7. The ability of a
self-activating caspase to execute cells prompted the acquisition by
viruses of speciﬁc Casp8 inhibitors (Mocarski et al., 2011). This
selected for host adaptation of necroptosis as a trap door to eliminate
viruses that suppress Casp8, built upon established RIP homotypic
interaction motif (RHIM) signaling pathways. RHIM-competitors
encoded by MCMV, HSV1 and HSV2 thus represent most recent
evolutionary adaptation in this ancient pathogen-host stand-off
(Kaiser et al., 2013; Mocarski et al., 2014).
MCMV vIRA employs an amino-terminal RHIM to interrupt
signal transduction leading to cell death and cytokine activation. In
Fig. 1. Evolutionary relationships in cell autonomous death pathways and virus-
encoded countermeasures. Programmed cell death (PCD) pathways include the
mitochondrial (or cell-intrinsic) death pathway that eliminates cells during devel-
opment and homeostatic turnover as well as in host defense (Kaiser et al., 2013;
Mocarski et al., 2011; McCormick and Mocarski, 2013; Galluzzi et al., 2008). Viral
(v)Bcl2 homologs and other virus-encoded mitochondrial suppressors block
mitochondrial PCD, establishing conditions that selected for a Casp8-like activity
to directly trigger effector caspases, bypassing mitochondrial Bcl2 function. Viruses
adaptation included Casp8-targeted cell death suppressors, some speciﬁc, like
herpesvirus vFLIPs, betaherpesvirus vICA, and some nonspeciﬁc, like the poxvirus
serpin, CrmA. RIP3-dependent necroptosis via RHIM-dependent interaction with
RIP1, TRIF or DAI, enables the host to bypass the impact of virus-encoded Casp8
inhibitors. The examples of MCMV vIRA and HSV1/HSV2 R1 RHIM signaling
competitors are the ﬁrst examples of viral suppressors of necroptosis (Guo et al.,
2015; Upton et al., 2008, 2010, 2012). Note that HSV1 ICP6 inhibits necroptosis in
human cells but promotes necroptosis in mouse cells (Huang et al., 2015; Wang
et al., 2014). This depiction is adapted from (Kaiser et al., 2013).
Fig. 2. Canonical and noncanonical RHIM-dependent activation of RIP3 kinase.
Canonical activation of necroptosis via RIP1 recruitment and activation RIP3
downstream of TNF family death receptors (TNFR1, Fas, TRAIL), highlighting the
known and predicted conformational changes that accompany this pathway (Chan
et al., 2014). Noncanonical activation of necroptosis via DAI downstream of MCMV
infection or via TRIF downstream of TLR3 and TLR4 activation, driving recruitment
and activation of RIP3, with predicted conformational changes. All forms of RHIM-
dependent activation of RIP3 are blocked by MCMV-encoded vIRA and converge on
the RIP3-dependent recruitment and phosphorylation events leading to plasma
membrane leakage and other outcomes characteristic of necroptosis.
Fig. 3. Formation and disruption of the ripoptosome and necrosome by HSV1 ICP6
and HSV2 ICP10. (A) The ripoptosome forms from cytosolic components. FADD
becomes activated downstream of TNF family death receptor (DR) activation, as
well as following T cell receptor (TCR), TLR and interferon receptor (IFNR)
activation, to recruit Casp8 and cFLIPL heterodimer via homotypic death effector
domain (DED) as well as RIP1 via a homotypic death domain (DD) interactions.
RIP1 recruits RIP3 via a common RHIM (shown as a red rectangle) and, when Casp8
activity is inhibited, triggers oligomerization that leads to an amyloid-like complex
that recruits MLKL into a necrosome that localizes to membranes and directs the
ﬁnal steps in necroptosis leading to membrane leakage. (B) Interaction of HSV1
ICP6 and HSV2 ICP10 with ripoptosome components in human cells. Cytosolic
ripoptosome components form HSV R1-dependent complexes via RHIM and Casp8
interaction domains discussed in the text.
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mice or humans, RIP1, DNA-induced activator of interferon (DAI)
and TIR-domain-containing adapter-inducing interferon β (TRIF)
can partner with RIP3, as depicted in Fig. 2 (Upton et al., 2010,
2012; Rebsamen et al., 2009; He et al., 2011; Kaiser et al., 2013).
The MCMV-encoded RHIM competitor, vIRA prevents activation of
RIP3 kinase activity, the subsequent recruitment of MLKL, and the
later steps leading to cell leakage (Kaiser et al., 2013). vIRA blocks
all consequences of RHIM-dependent signaling, including activa-
tion of NF-κB (Rebsamen et al., 2009; Upton et al., 2008; Kaiser
et al., 2008) even though the impact on this transcription factor
does not appear to impact infection in mouse cells or mice. Despite
the crucial role that MCMV M45-encoded vIRA plays in cell death
suppression, and the likely preservation of this mechanism in
other rodent betaherpesviruses, the HCMV UL45 is inactive (Hahn
et al., 2002; Patrone et al., 2003). Nevertheless, HCMV blocks
necroptosis during infection by employing a strategy that subverts
a later step in the pathway (Omoto et al,. 2015). The M45
homologs of herpes simplex virus (HSV)1 and HSV2 (UL39 gene
products, ICP6 and ICP10, respectively) have recently been shown
to employ a RHIM competitor mechanism in human cells (Guo
et al., 2015). Although analogous to MCMV vIRA, HSV cell death
suppressors ICP6 and ICP10 make use of an anti-apoptotic domain
separate from the RHIM to interact directly with Casp8 death
effector domains (Dufour et al., 2011), a function mediated by the
carboxyl-terminal RNR domain (Guo et al., 2015). Here, we will
focus on examples of virus-encoded RHIM-signaling inhibitors and
the contribution of Casp8 inhibition to unleashed necroptosis.
Activation and suppression of necroptosis
Necroptosis hinges on RIP3 RHIM-mediated signal transduction
that was initially characterized in cells undergoing cell death follow-
ing stimulation with TNF in the presence of caspase 8 inhibitor
(Fig. 3A) or in cells that lack Casp8 (Cho et al., 2009; He et al., 2009;
Zhang et al., 2009), and is the subject of up-to-date reviews (Sun and
Wang, 2014; Chan et al., 2014). RIP3 is a serine-threonine kinase that
recruits and phosphorylates the pseudokinase MLKL, controlling
oligomerization events at membranes that lead to cellular changes
including leakage of cytosolic contents (Sun et al., 2012; Zhao et al.,
2012; Murphy et al., 2013; Chen et al., 2013; Hildebrand et al., 2014).
RHIM-dependent interaction of RIP1 and RIP3 characterizes the
canonical form of this death pathway (Cho et al., 2009; He et al.,
2009; Zhang et al., 2009) and results in conformational changes and
amyloid-like oligomerization of a RIP1–RIP3 complex (Chan et al.,
2014; Li et al., 2012). Canonical TNFR1-mediated necroptosis requires
the protein kinase activity of RIP1 in addition to RHIM interaction
with RIP3. RIP3 activation and execution of necroptosis may proceed
independent of RIP1. DAI as well as TRIF can naturally partner with
RIP3 and trigger a noncanonical necroptosis, independent of RIP1
RHIM and kinase activities (Upton et al., 2010, 2012; Kaiser et al.,
2013). Interestingly, experiments have substantiated the noncanoni-
cal pathway even downstream of death receptors (Fig. 1) (Moujalled
et al., 2013; McQuade et al., 2013; Cho et al., 2011). Regardless of the
involvement of RIP1, RIP3 must autophosphorylate itself to facilitate
interaction with and subsequent phosphorylation of MLKL (Kaiser
et al., 2013; Chan et al., 2014; Wu et al., 2013) (Fig. 2). A cytosolic
Casp8-containing complex, called Complex IIB (Micheau and
Tschopp, 2003) or the ripoptosome (Chan et al., 2014; Tenev et al.,
2011; Feoktistova et al., 2012, 2011), forms downstream of TNFR1 or
of TRIF-dependent signaling pathways controlled by TLR3 or TLR4.
This complex is increasingly recognized to control apoptotic as well
as necroptotic outcomes (Chan et al., 2014; Mandal et al., 2014) after
assembling from preexisting cytosolic components in a manner that
is independent of pro-apoptotic caspase activity as well as mitochon-
drial function (Tait et al., 2013). The ripoptosome is assembled
around Casp8-cFLIPL heterodimer in association with FADD to which
RIP1 and RIP3 are recruited through well-established protein–protein
homotypic interaction domains depicted in Fig. 3A. This assembly
has been the subject of many reviews (Sun and Wang, 2014; Chan
et al., 2014; van Raam and Salvesen, 2012). MLKL is recruited and
phosphorylated by RIP3 kinase within a necrosome complex
(Murphy et al., 2013; Hildebrand et al., 2014; Cai et al., 2014; Wang
et al., 2014; Dondelinger et al., 2014) resulting in MLKL conforma-
tional changes and oligomerization that result in membrane associa-
tion, as well as the pattern of disruption and leakage (Sun and Wang,
2014; Chan et al., 2014).
Casp8 inhibition has long been recognized as a key factor in the
induction of necrotic death (Holler et al., 2000; Vercammen et al.,
1998) and is a crucial feature in terms of how this pathway is
unleashed in virus-infected cells (Kaiser et al., 2013; Mocarski et al.,
2011). Besides suppression of apoptosis, inhibition of Casp8 also
fundamentally affects the availability of key ripoptosome compo-
nents. The susceptibility of RIP1 (Lin et al., 1999) and RIP3 (Feng et al.,
2007) to Casp8 cleavage-dependent inactivation of pro-necrotic
kinase activity suggests that both of these pro-necrotic kinases are
silenced by Casp8 (Sun and Wang, 2014; Chan et al., 2014). Although
the heterodimeric complex of Casp8 and cFLIPL elaborates a basal
protease activity that may be sufﬁcient to inactivate RIP1 and/or RIP3,
details of this regulatory process have not yet been worked out.
Whereas Casp8 suppression by vICA is needed during natural infec-
tion to block apoptosis in macrophages (Cicin-Sain et al., 2008),
MCMV-infected cells become sensitized to necroptosis such that vIRA
is necessary to suppress the RHIM-dependent recruitment of RIP3 by
DAI in all infected host tissues (Upton et al., 2010, 2012). Without an
intact RHIM in vIRA, MCMV cannot sustain infection in wild-type
mice. However, normal infection is restored in RIP3- or DAI-deﬁcient
strains of mice. Mice carrying kinase inactive RIP3 also normalize
replication of vIRA-deﬁcient MCMV (Mandal et al., 2014), consistent
with the essential contribution of this pro-necrotic kinase activity to
host defense. The investigation of cell death suppressor mutants of
MCMV has revealed the importance of deﬂecting both Casp8-
mediated apoptosis and RIP3-mediated necroptosis (McCormick and
Mocarski, 2013). Necroptosis is triggered in tissue-resident cells
regardless of whether the same cells are sensitive to apoptosis.
Importantly, studies with vIRA-deﬁcient MCMV have revealed that
necroptosis may be unleashed in any virus-infected cell; however,
mouse or human cells placed into culture vary in their levels of RIP3
and therefore vary in their susceptibility to this death pathway. The
reasons why cultured cells tend to lose RIP3 (as well as MLKL)
expression is presently unknown, but certainly suggests that cell
culture selects against the retention of necroptotic machinery. In
addition to herpesviruses, this alternate death is likely to be modu-
lated by poxviruses and other DNA viruses known to block Casp8
activity (Mocarski et al., 2011; Hedrick et al., 2010).
Cell death outcomes are strongly inﬂuenced by posttranslational
modiﬁcation that acts as a scaffold such as those provided by K63 or
M1 (linear) polyubiquitination (Silke and Meier, 2013; Walczak,
2011). RIP1 seems to be the most important target of such
modiﬁcations, in line with its contribution to balancing death
outcomes emanating from the ripoptosome (Feoktistova et al.,
2012; Walczak, 2011; Kaiser et al., 2014; Weinlich and Green,
2014). Compromised K63 or linear polyubiquitination increases
susceptibility of cells to apoptotic as well as necroptotic death
(Kaiser et al., 2013). Inhibitors and mutants affecting either of two
distinct E3 ubiquitin ligase complexes, cellular inhibitor of apoptosis
(cIAP)1/cIAP2 (Silke and Meier, 2013) or linear ubiquitination chain
assembly complex (LUBAC) (Walczak, 2011) have been employed to
show the importance of polyubiquitination in dictating sensitivity
to death signaling (He et al., 2009; Tenev et al., 2011; Feoktistova
et al., 2011; Vanlangenakker et al., 2011; Varfolomeev et al., 2007;
Gerlach et al., 2011). Although the polyubiquitination machinery is
not a known target of mammalian virus-encoded cell death
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suppressors, the ﬁrst IAP ever identiﬁed emerged from studies in
baculoviruses where virus-encoded IAPs suppress cell death to
sustain infection (Crook et al., 1993; Birnbaum et al., 1994). To date
only large DNA viruses infecting arthropods encode IAP-like sup-
pressors of apoptosis (Clem, 2005). Interestingly, the noncanonical
induction of necroptosis that occurs in MCMV M45 mutant virus
infected cells is insensitive to IAP1/IAP2 antagonists, consistent with
known RIP1 independent characteristics of the pathway (Upton
et al., 2010, 2012). Only time and additional investigation will reveal
whether mammalian and insect cells differ in some fundamental
way in harnessing IAP function for host defense.
Uncontrolled necroptosis undermines development and tissue
homeostasis
The discovery that midgestational death in Casp8 or FADD-
deﬁcient mice results from unrestricted RIP3- and RIP1-dependent
death (Oberst et al., 2011; Kaiser et al., 2011; Zhang et al., 2011)
completely revised the thinking about ripoptosome function in
development and inﬂammatory disease. These investigations,
together with incisive observations on Casp8- or FADD-deﬁcient T
cells (Lu et al., 2011; Ch'en et al., 2011) revealed how dysregulation of
death pathways during development as well as during the T cell
response to antigen impact cell fate. The complex dialog between
FADD/Casp8 and pro-necrotic kinases is further bolstered by an
investigation of FADD-deﬁcient keratinocytes (Bonnet et al., 2011)
and intestinal epithelium (Welz et al., 2011) as well as in a number of
other settings (Mocarski et al., 2011, 2014; Sun andWang, 2014; Chan
et al., 2014; Weinlich et al., 2011). Thus, it is now widely understood
that midgestational death due to germ line deﬁciency in Casp8 (or
FADD) is due to canonical RIP1-RIP3 necroptosis, particularly because
the phenotype is reversed by either kinase-inactive RIP3 (Mandal
et al., 2014; Newton et al., 2014) or kinase-inactive RIP1 (Kaiser et al.,
2014). Both RIP1 and RIP3 kinase activities contribute directly to fetal
demise. Consistent with the observations on Casp8 and FADD, serious
defects are observed with germ line deﬁciency in other ripoptosome
components. cFLIP-deﬁcient (Dillon et al., 2012) or RIP1-deﬁcient
mice (Kaiser et al., 2014; Dillon et al., 2014; Rickard et al., 2014) die
during development but are fully rescued by the combined elimina-
tion of apoptotic (Casp8 or FADD) and necroptotic (RIP3 or MLKL)
machinery. Thus, mice deﬁcient in multiple complementary compo-
nents are fully viable, fertile, and where examined (Kaiser et al.,
2014), immunocompetent and able to clear virus infection. The
picture that emerges from these studies and from a growing number
of examples where disruption of Casp8 is performed in a tissue-
speciﬁc manner (Sun and Wang, 2014; Chan et al., 2014) is that the
balance of Casp8-dependent apoptosis and RIP3-dependent necrop-
tosis is crucial to sustain tissue homeostasis (Mocarski et al., 2014;
Chan et al., 2014). The common ability of death receptors, TLRs, T cell
receptors, genotoxic stress and interferon receptors as well as virus
infection to drive innate immune cell death as well as innate immune
cytokine activation indicates that the ripoptosome may act as a
pathogen supersensor to guard mammalian cells from insult (Kaiser
et al., 2013). Perturbation of the ripoptosome undermines develop-
ment even though its function is dispensable for either development
or tissue homeostasis.
It is important to note that developmental consequences of
mutant ripoptosome components only show modest dependence
on TNF signaling despite the fact that canonical, RIP1-dependent
activation of RIP3 kinase activity and RHIM signal transduction are
crucial to the demise of mutant mice (Cho et al., 2009; Kaiser et al.,
2013, 2011; He et al., 2009; Zhang et al., 2009; Oberst et al., 2011). The
ripoptosome forms under a wide variety of innate signaling condi-
tions, executing either apoptosis or necroptosis (Kaiser et al., 2013).
The recent demonstration that the ripoptosome is also triggered by
conformational changes in RIP3 independent of its pronecrotic kinase
activity (Mandal et al., 2014) reveals a remarkable capacity of this
protein kinase to regulate caspase activation in addition to necropto-
sis. RIP3 deﬁciency itself does not cause any developmental problems
(Newton et al., 2004) but reveals modest innate immune response
dysregulation (Moriwaki et al., 2015). The potential for RIP3 kinase
domain mutants as well as small molecule kinase inhibitors to trigger
apoptosis dependent on RIP1 and RIP3 scaffold functions independent
of activity of these kinases (Mandal et al., 2014; Newton et al., 2014)
expanded the settings where the ripoptosome controls cell fate.
Further dissection of the scaffold versus the enzymatic roles of RIP1
as well as RIP3 will provide further insights into the mechanism
(s) underlying alternate death outcomes.
Evolutionary adaptation of innate immune programmed cell
death in host defense
Evolutionary relationships of Casp8-mediated apoptosis and
RIP3-mediated necroptosis pathways in response to viral suppres-
sors have been reviewed (Kaiser et al., 2013) and are illustrated in
Fig. 1. Our work with MCMV brought to light the importance of
RIP3-dependent necroptosis as a host defense mechanism (Upton
et al., 2012). Many diverse innate and adaptive immune mechan-
isms ranging from interferons to antibodies and T cells mediate
control over pathogens, but only necroptosis has been shown to
completely prevent a herpesvirus such as MCMV from infecting
its natural host, even when high doses of virus are used. This
can be attributed to the unique ability of necroptosis to eliminate
virus-infected cells before production of progeny can occur, thereby
shutting down the infection. Because the MCMV vIRA completely
blocks the elaboration of necroptosis during MCMV infection, this
remarkably potent host defense pathway becomes effectively
neutralized. This absolutely fascinating pathogen–host relationship
extends to human cell settings where necroptosis is targeted by
HCMV (Omoto et al., 2015) as well as HSV gene products (Guo et al.,
2015). In all of these settings, we hypothesize that Casp8, together
with its partners, FADD and cFLIPL, forms a pathogen supersensor
(Kaiser et al., 2013) and triggers cell autonomous defense pathways
that include cell death and cytokine production (Mocarski et al.,
2014), although, in mice, death pathways predominate innate
signaling and play out completely independent of interferon and
inﬂammatory cytokine function. The subversion tactics by herpes-
viruses have codiﬁed the importance of neutralizing these path-
ways in pathogenesis.
Suppression of necroptosis by HSV
HSV1 suppresses programmed cell death induced by awide variety
of insults (Galvan and Roizman, 1998), relying on the regulatory
protein ICP4 as well as protein kinase US3 (Leopardi and Roizman,
1996; Leopardi et al., 1997). In addition to US3 (Benetti and Roizman,
2004; Munger and Roizman, 2001), early viral gene products gD (Zhou
et al., 2003; Zhou and Roizman, 2002) and, in particular, R1 (Dufour
et al., 2011; Perkins et al., 2002a, 2002b; Langelier et al., 2002;
Chabaud et al., 2007) are able to inhibit apoptosis, albeit in a cell-
type speciﬁc manner (Han et al., 2009; Aurelian, 2005). HSV1 also
manipulates apoptosis as a component of latency in rodent neurons
(Perng et al., 2000; Du et al., 2012). The HSV1 and HSV2 R1 proteins,
ICP6 and ICP10, suppress death receptor-dependent apoptosis by
interacting with death effector domains of Casp8 via a conserved
C-terminal RNR domain (Dufour et al., 2011). MCMV vIRA known to
block apoptosis as well as neroptosis (Upton et al., 2008, 2010, 2012),
but does not bind to Casp8 (Guo et al., 2015). HSV R1-mediated
inhibition of Casp8 functionmay be analogous to betaherpesvirus vICA
(McCormick et al., 2003; Skaletskaya et al., 2001). Until recently, little
attention was given to necroptosis, although there have been
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longstanding clues that caspase-independent pathways may dominate
under certain conditions in HSV-infected cells and tissues (Aurelian,
2005; Galvan et al., 1999; Peri et al., 2008, 2011). Intriguingly, ICP6 and
ICP10 exhibit sequence homology with the N-terminal RHIM of MCMV
M45 and cellular RHIM-containing proteins (Lembo and Brune, 2009).
This RHIM-like amino acid sequence is located in the amino-terminal
extension of all R1 homologs encoded by the primate alphaherpes-
viruses and rodent betaherpesviruses. Recent comprehensive investi-
gation of HSV1 ICP6 reveals an ability of this RHIM-like region to
interact with RIP1 and RIP3 in human cells (Guo et al., 2015) as well as
in mouse cells (Huang et al., 2015; Wang et al., 2014) (Fig. 3B);
however, the RHIM-dependent interaction yields apparently opposite
biological consequences in human versus mouse cells. Both HSV1 ICP6
and HSV2 ICP10 act as RHIM competitors in necroptosis-sensitive
human cells (Guo et al., 2015), behavior that is reminiscent of MCMV
vIRA (Upton et al., 2010, 2012). This behavior is consistent with a role
in counteracting host defense. In contrast to the behavior in human
cells, HSV1 ICP6 promotes necroptosis in mouse cells, where the
RHIM-like region activates the pro-necrotic kinases (Huang et al.,
2015; Wang et al., 2014). This is most dramatically demonstrated by
comparing infection of parental WT HSV1 with an ICP6 mutant
(ΔICP6) HSV1. Infection with ΔICP6 HSV1 mutant renders human
cells highly sensitive to TNF due to the induction of apoptosis as well
as necroptosis (Guo et al., 2015); whereas, infection with this mutant
virus delays virus-induced necroptosis in mouse cells (Huang
et al., 2015; Wang et al., 2014) (Fig. 3B). These ﬁndings raise important
questions about the role of death pathways in modulating cross-
species infections as well as about the reliance on rodents as surrogate
hosts in studies of HSV1 pathogenesis and latency. It remains to be
determined whether HSV2 ICP10 acts similarly to HSV1 ICP6 in mice.
Importantly, and in contrast to the species-speciﬁc behavior of HSV1
ICP6, MCMV vIRA blocks either death receptor or virus-induced
necroptosis function in human or mouse cells (Guo et al., 2015).
Indeed, a swap of the M45 RHIM into HSV1 ICP6 converted the latter
from an inducer to a suppressor of necroptosis in mouse cells (Huang
et al., 2015).
The ability of HSV1 ICP6 and HSV2 ICP10 to bind Casp8 is integral to
their suppression activity against necroptosis in human cells (Guo et al.,
2015). Early (Dufour et al., 2011) and recent studies (Guo et al., 2015)
demonstrate that Casp8 binding is mediated by the large carboxyl-
terminal region of HSV R1 proteins, a region that is also responsible for
ribonucleotide reductase activity. The amino-terminal region carrying
the RHIM-like element is sufﬁcient for interaction with RIP1 or RIP3 in
a RHIM-dependent fashion, but the ability to block necroptosis in
infected cells requires interaction with both the RIP1/RIP3 and Casp8-
binding regions. Importantly, HSV1-infected cells are effectively sensi-
tized to TNF-induced necroptosis by the Casp8-binding domain of ICP6
or ICP10. Importantly, ICP6mutRHIM virus-infected cells die prema-
turely following TNF treatment due to the suppression of Casp8 activity
in the absence of RHIM competitor activity (Guo et al., 2015). Curiously,
mouse cells are rescued from ICP6-induced necroptosis when infected
with this same virus, conﬁrming the contribution of RHIM signaling to
the induction of the pathway in a species-speciﬁc fashion (Huang et al.,
2015). From these recent studies, HSV1 ICP6 and HSV2 ICP10 emerge as
important suppressors of necroptosis in cells from their natural host
species, where Casp8 suppression sensitizes to necroptosis. This pre-
vents RHIM signal competition, activation of RIP3 and recruitment of
MLKL into a necrosome complex.
Perspectives
Pathogenesis studies in mice have unambiguously identiﬁed the
cognate pathways targeted by virus-encoded cell death suppressors in
natural pathogen-host settings, such as infection with MCMV, under-
scoring the importance of speciﬁc host defense mechanisms, including
programmed cell death. Using MCMV mutants M45mutRHIM, both
RIP3 and DAI were found to be the cognate host cell targets of RHIM
competitor activity. When they associate, necroptosis is activated to
eliminate infected cells in all exposed tissues (Upton et al., 2008, 2010,
2012). These studies opened the way to show that RIP3 necroptosis
underlies the phenotype of germ line Casp8-deﬁcient mice (Kaiser
et al., 2011) and that perinatal lethality due to combined effects of
Casp8-dependent apoptosis and RIP3-dependent necroptosis under-
lies RIP1-deﬁciency (Kaiser et al., 2014). Along the way, we showed
that the combined elimination of Casp8 and RIP3 programmed cell
death pathways are remarkably dispensable for mammalian develop-
ment, viability, fertility (Kaiser et al., 2014) and the ability to mount a
fully developed T cell response to control viral infection (Kaiser et al.,
2014). The key components of the ripoptosome become dispensable
for development when eliminated in precise combinations that
respect the ability of single mutants to dysregulate cell death by
unleashing alternate cell death pathways, pathways that are elabo-
rated in mammals to control pathogens. Recent demonstration that
TNF-dependent necroptosis plays out against HSV1 in human cells and
is blocked by the HSV1 and HSV2 R1 proteins adds signiﬁcantly to the
growing understanding of the antiviral role of necroptosis. These
observations reveal viral evasion strategies that have the potential to
prevent cross-species infections. The specter of necroptosis as a cross-
species restriction factor, however, must be pursued further. Necrop-
tosis emerges as a way to eliminate viruses capable of inhibiting
Casp8, as illustrated initially by the behavior of vaccinia as well as by a
growing body of data on MCMV infection and HSV1 infection,
strategies that are likely to be usurped by other mammalian viruses.
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